Smooth muscle cell response to mechanical injury involves intracellular calcium release and ERK1/ERK2 phosphorylation

Exp Cell Res. 2001 Sep 10;269(1):88-96. doi: 10.1006/excr.2001.5308.

Abstract

We have investigated possible signaling pathways coupled to injury-induced ERK1/2 activation and the subsequent initiation of vascular rat smooth muscle cell migration and proliferation. Aortic smooth muscle cells were cultured to confluency and subjected to in vitro injury under serum-free conditions. In fluo-4-loaded cells, injury induced a rapid wave of intracellular Ca(2+) release that propagated about 200 microm in radius from the injured zone, reached a peak in about 20 s, and subsided to the baseline within 2 min. The wave was abolished by prior treatment with the sarcoplasmic reticulum ATPase inhibitor thapsigargin, but not by omission of extracellular Ca(2+). ERK1/2 activation reached a peak at 10 min after injury and was inhibited by the MEK1 inhibitor PD98059, as well as by thapsigargin, fluphenazine, genistein, and the Src inhibitor PP2. These inhibitors also reduced [(3)H]thymidine incorporation and migration of cells into the injured area determined at 48 h after injury. These results show that mechanical injury to vascular smooth muscle cells induces a Ca(2+) wave which is dependent on intracellular Ca(2+) release. Furthermore, the injury activates ERK1/2 phosphorylation as well as cell migration and replication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arteries / injuries*
  • Arteries / metabolism
  • Arteries / physiopathology
  • Calcimycin / pharmacology
  • Calcium / metabolism*
  • Calcium Channel Blockers / pharmacology
  • Calmodulin / antagonists & inhibitors
  • Calmodulin / metabolism
  • Cell Division / drug effects
  • Cell Division / physiology*
  • Cell Movement / drug effects
  • Cell Movement / physiology*
  • Cells, Cultured / drug effects
  • Cells, Cultured / metabolism
  • DNA / biosynthesis
  • DNA / drug effects
  • Egtazic Acid / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / pharmacology
  • Fluphenazine / pharmacology
  • Genistein / pharmacology
  • Intracellular Fluid / drug effects
  • Intracellular Fluid / metabolism*
  • Ionomycin / pharmacology
  • Ionophores / pharmacology
  • Male
  • Mitogen-Activated Protein Kinases / drug effects
  • Mitogen-Activated Protein Kinases / metabolism*
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • Octanols / pharmacology
  • Phosphorylation / drug effects
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Stress, Mechanical
  • Thapsigargin / pharmacology
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Calmodulin
  • Enzyme Inhibitors
  • Flavonoids
  • Ionophores
  • Octanols
  • Calcimycin
  • Egtazic Acid
  • Ionomycin
  • Thapsigargin
  • DNA
  • Verapamil
  • Genistein
  • Protein-Tyrosine Kinases
  • Mitogen-Activated Protein Kinases
  • Fluphenazine
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Calcium